This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Clean and dry the affected area and apply the cream. Wash your hands after applying, unless hands are the affected area.
Halobet ES Cream is a combination of two medicines: Halobetasol (topical) and Salicylic Acid which treat eczema and psoriasis. Halobetasol (topical) is a steroid medicine. It blocks the production of certain chemical messengers (prostaglandins) that make the skin red, swollen and itchy. Salicylic Acid is a keratolytic medicine which breaks down keratin clumps, removes dead skin cells and softens the skin. It also enhances the absorption of Halobetasol (topical) into the skin.
Halobet ES Cream may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Halobet ES Cream is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
It is not known whether Halobet ES Cream alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Halobet ES Cream is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Halobet ES Cream may not be needed in these patients. Please consult your doctor.
Halobet ES Cream is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Halobet ES Cream may not be needed in these patients. Please consult your doctor.
“The following are the results of on-going survey on 1mg.com for Halobet ES Cream. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 8th Mar 2017.